We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
67 result(s) found, displaying 11 to 20
-
Cancellation by sponsorRequested by Celltrion Healthcare Australia Pty Ltd
-
Jul-2025Prescription medicine evaluationActive ingredient: Aflibercept.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OSENVELT denosumab (rch) 70 mg/mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for STOBOCLO denosumab (rch) 60 mg/mL solution for injection pre-filled syringe.
-
EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe (431931)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe. -
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection vial with needle.
-
Prescription medicine registrationActive ingredients: Tocilizumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMLYCLO omalizumab (rch) 75 mg/0.5 mL solution for injection in a pre-filled syringe with needle guard.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMLYCLO omalizumab (rch) 150 mg/ mL solution for injection in a pre-filled syringe with needle guard.
-
Prescription medicine registrationActive ingredients: Denosumab.